Digital diet and exercise for liver scarring in fatty liver disease
Part of Digestive system clinical trials.
This trial tests whether a digital diet and exercise program can reduce liver scarring in people with MASLD (fatty liver disease not caused by alcohol). You would use an app on your smartphone to follow the program at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with MASLD by a liver doctor
- Your FibroScan (liver stiffness test) shows a score of 8 or higher
- You own a smartphone with a data plan
- You are not drinking more than 14 units of alcohol per week
- You are not currently pregnant or planning pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital lifestyle program (diet and activity coaching) to help people with HIV and fatty liver disease lose weight. It aims to see if the program can reduce body fat in the liver and improve overall health.
This study tests whether a high-intensity exercise program can improve liver function and insulin sensitivity in people with MASLD (a type of fatty liver disease). It may help you if you are looking for a non-drug way to manage your condition.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This trial uses digital twin technology to better detect, treat, and monitor metabolic fatty liver disease (MAFLD) and its complications like heart disease and cirrhosis. It may help create more personalized care plans.
This study tests whether a live-streamed exercise program can improve liver health in pregnant women who have MASLD (a type of fatty liver disease). If you join, you'll be asked to follow exercise sessions at home while researchers track your liver health.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.